In Russia introduced a vaccine against the coronavirus of 18 volunteers
In Russia, the first 18 volunteers were injected with the Russian vaccine against the coronavirus, which was developed by the Ministry of defence of the Russian Federation jointly with the National research centre of epidemiology and Microbiology named after academician Gamalei. About it reports the edition Lenta.ru with reference to the press service of the Ministry.
Test participants were divided into two groups of nine people. They were introduced to different components of the vaccine. The defense Ministry said that any complaints and adverse reactions and complications were recorded.
The publication writes that the country’s Ministry of health on June 19 announced the vaccination of the first Russian volunteers. After that, the participants in the study put in the hospital for 28 days under the supervision of doctors.
The study involved two forms of the vaccine powder and liquid.
The vaccine trials are carried out in two Moscow medical institutions: in the Main military clinical hospital named after academician Burdenko, and at First Moscow state medical University named after Sechenov.
June 11 edition of the Wall Street Journal wrote that the Russian scientists hasten to answer the request of President Vladimir Putin to develop a vaccine against coronavirus by the fall; in the country investigated 10 experimental vaccines. One of the drugs tested for the military.
16 June it became known that the Russian Ministry of health allowed testing of the vaccine against the coronavirus in humans.
Flash coronavirus infection COVID-19 began in late 2019 in China. March 11, 2020, the world health organization declared the spread of the coronavirus pandemic.
Who believe that the coronavirus would pose a serious threat, until they invent a vaccine. According to the head of the European Agency of medicines Marco Kavaleri, in the best case, the vaccine will be ready next year. May 15, U.S. President Donald trump suggested that the coronavirus vaccine can be developed and tested by the end of 2020.
